The report "Tumor Profiling Market by Application (Clinical, Research), Technology (Immunoassay, Hybridization (PCR, In Situ Hybridization, DNA/RNA Microarray), NGS, Mass Spectrometry), Cancer Type (Breast, Lung, Prostate, Colorectal) - Global Forecast to 2022".
Tumor Profiling Market is projected to reach USD 8.74 Billion by 2022 from USD 5.26 Billion in 2017, at a CAGR of 10.7%. Major factors fueling the growth of the market include increasing number of cancer cases across the globe, the increasing utility of biomarkers, and availability of funding for cancer research. On the other hand, high capital investments and low benefit ratio for biomarkers used in cancer/tumor profiling are expected to limit the cancer/tumor profiling market growth to a certain extent. Factors such as the increasing demand for personalized medicine and point-of-care diagnostic tests in cancer/tumor profiling are expected to offer a wide range of growth opportunities for players in the cancer/tumor profiling market.
Download PDF Sample Pages of Varicose Vein Treatment Market @: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1250
Scope of the Report
This research report categorizes the global market on the basis of technology, cancer type, application, and region
Global Tumor Profiling Market, by Application
Speak with our Experts @: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=1250
Major players operating in the cancer profiling market include Illumina (US), QIAGEN (Netherlands), NeoGenomics Laboratories (US), HTG Molecular Diagnostic (US), and Genomic Health (US). These players focus on inorganic strategies such as acquisitions, agreements, and collaborations as well as organic strategies such as product launches and expansions to sustain their growth in the tumor profiling market.
Other major players in the market include Caris Life Sciences. (U.S.), Helomics Corporation (U.S.), and NanoString Technologies, Inc. (U.S.).
Objectives of the Study
Get Sample Report with all Graphs & Charts related to it @: https://www.marketsandmarkets.com/requestsampleNew.asp?id=1250
About MarketsandMarkets™: MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, and strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
Email: sales@marketsandmarkets.com
Tumor Profiling Market is projected to reach USD 8.74 Billion by 2022 from USD 5.26 Billion in 2017, at a CAGR of 10.7%. Major factors fueling the growth of the market include increasing number of cancer cases across the globe, the increasing utility of biomarkers, and availability of funding for cancer research. On the other hand, high capital investments and low benefit ratio for biomarkers used in cancer/tumor profiling are expected to limit the cancer/tumor profiling market growth to a certain extent. Factors such as the increasing demand for personalized medicine and point-of-care diagnostic tests in cancer/tumor profiling are expected to offer a wide range of growth opportunities for players in the cancer/tumor profiling market.
Download PDF Sample Pages of Varicose Vein Treatment Market @: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1250
Scope of the Report
This research report categorizes the global market on the basis of technology, cancer type, application, and region
Global Tumor Profiling Market, by Application
- Clinical Applications
- Research Applications
- Immunoassays
- Hybridization
- Next-generation Sequencing
- Mass Spectroscopy
- Other Technologies (Pyrosequencing and Sanger Sequencing)
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma Cancer
- Other Cancer Types (Non-Hodgkin’s Lymphoma, Melanoma, Leukemia, Thyroid, Bladder, and Kidney)
- North America
- US
- Canada
- Europe
- Asia Pacific
- Rest of the World (RoW)
Speak with our Experts @: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=1250
Major players operating in the cancer profiling market include Illumina (US), QIAGEN (Netherlands), NeoGenomics Laboratories (US), HTG Molecular Diagnostic (US), and Genomic Health (US). These players focus on inorganic strategies such as acquisitions, agreements, and collaborations as well as organic strategies such as product launches and expansions to sustain their growth in the tumor profiling market.
Other major players in the market include Caris Life Sciences. (U.S.), Helomics Corporation (U.S.), and NanoString Technologies, Inc. (U.S.).
Objectives of the Study
- To define, describe, and forecast the tumor profiling market on the basis of application, technology, cancer type, and region
- To provide a detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contribution to the total market
- To analyze the opportunities in the market for stakeholders and details of a competitive landscape for market leaders
- To forecasting the revenue of market segments with respect to four main geographies (along with countries), namely, North America, Europe, Asia Pacific, and the RoW
- To profile key players and comprehensively analyze their market shares and core competencies
- To track and analyze competitive developments such as collaborations, new product developments, product enhancements, and R&D activities in the tumor profiling market
Get Sample Report with all Graphs & Charts related to it @: https://www.marketsandmarkets.com/requestsampleNew.asp?id=1250
About MarketsandMarkets™: MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, and strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
Email: sales@marketsandmarkets.com
Comments
Post a Comment